Literature DB >> 2012455

Female gout. Clinical spectrum and uric acid metabolism.

J G Puig1, A D Michán, M L Jiménez, C Pérez de Ayala, F A Mateos, C F Capitán, E de Miguel, J B Gijón.   

Abstract

We reviewed the clinical features and uric acid metabolism in 37 female patients with gout. In 32 female patients (86%), gout was diagnosed after menopause. Among the five premenopausal patients, four had renal insufficiency and one had superactivity of phosphoribosylpyrophosphate synthetase. More than 50% of the female patients had osteoarthritis, hypertension, or renal insufficiency or were treated with diuretics. Comparison with 220 male patients with gout showed that female patients developed gout significantly later, more frequently had associated diseases, and more often were receiving diuretics, whereas significantly more male than female patients had alcoholism. The articular features of gout were similar in both groups. However, the prevalence of tophi was higher and its localization different in female than in male patients. Female patients with gout had a higher mean serum urate concentration and a lower mean urinary uric acid excretion than did male patients with gout. These differences were significant and independent of the effects of age, renal insufficiency, alcoholism, or previous diuretic intake. Renal underexcretion of uric acid appears to be more severe in female than in male patients with gout.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012455     DOI: 10.1001/archinte.151.4.726

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  35 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Characteristics of gouty arthritis in the Guatemalan population.

Authors:  C O Garcia; A G Kutzbach; L R Espinoza
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 3.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Long non-coding RNAs in heart failure: an obvious lnc.

Authors:  Hamid El Azzouzi; Pieter Adrianus Doevendans; Joost Petrus Gerardus Sluijter
Journal:  Ann Transl Med       Date:  2016-05

5.  Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study.

Authors:  Shih-Yang Chen; Ching-Lang Chen; Ming-Lai Shen
Journal:  Clin Rheumatol       Date:  2006-05-11       Impact factor: 2.980

6.  Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.

Authors:  Young Hee Rho; Na Lu; Christine E Peloquin; Ada Man; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-10-02       Impact factor: 19.103

7.  Obesity and younger age at gout onset in a community-based cohort.

Authors:  Mara A McAdams DeMarco; Janet W Maynard; Mary Margret Huizinga; Alan N Baer; Anna Köttgen; Allan C Gelber; Josef Coresh
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

8.  The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort.

Authors:  Hadar Duskin-Bitan; Eytan Cohen; Elad Goldberg; Tzippy Shochat; Amos Levi; Moshe Garty; Ilan Krause
Journal:  Clin Rheumatol       Date:  2014-02-13       Impact factor: 2.980

9.  Clinical value of serum uric Acid in patients with suspected coronary artery disease.

Authors:  Hong Euy Lim; Seong Hwan Kim; Eung Ju Kim; Jin Won Kim; Seung Woon Rha; Hong Seog Seo; Chang Gyu Park
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

Review 10.  "Clinical features of women with gout arthritis." A systematic review.

Authors:  K J M Jansen Dirken-Heukensfeldt; T A M Teunissen; H van de Lisdonk; A L M Lagro-Janssen
Journal:  Clin Rheumatol       Date:  2010-01-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.